molecular
diagnost
test
divid
two
primari
group
first
test
design
detect
presenc
mutat
human
genom
associ
specif
diseas
test
need
perform
specif
individu
lifetim
cours
discoveri
addit
diseaselink
mutat
may
initi
addit
investig
second
group
molecular
diagnost
assay
design
detect
infecti
agent
espi
et
al
recurr
mutat
specif
associ
tumor
patient
past
kannim
et
al
bacteri
viral
fungal
parasit
infect
erad
recur
time
futur
requir
repetit
molecular
assay
detect
viral
load
human
immunodefici
viru
hiv
hepat
c
viru
hcv
use
monitor
therapeut
efficaci
clinic
cours
phillip
et
al
bain
minim
residu
diseas
detect
refer
analysi
tissuecel
patient
previous
diagnos
malign
evalu
therapi
complet
success
rare
malign
cell
present
exampl
monitor
mutat
identifi
major
philadelphia
chromosomeneg
myeloprolif
disord
minim
residu
diseas
follow
specif
treatment
kannim
et
al
colleg
american
pathologist
patient
prepar
specimen
handl
editori
board
initi
twoyear
effort
write
final
fascicl
vii
entitl
refer
guid
diagnost
molecular
patholog
flow
cytometri
kiechl
et
al
book
publish
entri
divid
human
nuclear
genom
mutat
human
mitochondri
genom
mutat
kiechl
et
al
infecti
diseas
molecular
detect
assay
virus
bacteria
parasit
fungi
tabl
past
year
mani
chang
refin
relationship
use
infecti
diseas
molecular
diagnost
test
patient
care
made
espi
et
al
new
strategi
devis
nucleic
acid
purif
amplif
mardi
mani
advanc
molecular
patholog
diagnost
technolog
describ
handbook
follow
review
focu
issu
requir
vigil
face
continu
progress
understand
pathogenesi
progress
infecti
diseas
goal
improv
current
approach
detect
infecti
diseas
combin
widespread
agricultur
industri
develop
result
increas
densiti
human
live
close
proxim
lifestyl
chang
rural
exist
brought
human
closer
proxim
wild
anim
harbor
potenti
futur
human
pathogen
wolf
et
al
propos
five
stage
pathogen
exclus
infect
anim
stage
must
progress
transform
pathogen
exclus
infect
human
stage
author
select
infecti
diseas
common
temper
climat
common
tropic
climat
evalu
higher
proport
diseas
transmit
insect
vector
belong
stage
pathogen
temper
climat
compar
tropic
wolf
et
al
anim
reservoir
common
tropic
compar
temper
climat
wolf
et
al
jone
et
al
explor
geograph
locat
chapter
emerg
infecti
diseas
determin
steadi
increas
diseas
identif
maximum
attribut
emerg
hiv
jone
et
al
event
caus
drugresist
microb
primarili
locat
high
latitud
develop
countri
readili
avail
antibiot
locat
jone
et
al
today
hospitalacquir
antibiot
resist
may
occur
gramposit
gramneg
bacteri
tabl
methicillinresist
staphylococcu
aureu
mrsa
first
describ
zitterkopf
bacteri
cultur
chromagar
requir
greater
hour
mrsa
growth
meanwhil
patient
test
isol
sinc
mrsa
transmiss
hour
person
person
may
high
depend
distanc
two
individu
polymeras
chain
reaction
pcr
probe
identifi
meca
gene
encod
methicillin
resist
decreas
turnaround
time
detect
hour
sensit
cultur
sinc
screen
assay
current
reimburs
hospit
patient
effort
reduc
mrsa
preval
hospit
becom
exercis
cost
avoid
addit
cost
care
patient
mrsa
infect
rang
per
patient
compar
patient
methicillinsensit
aureu
zitterkopf
rate
subsequ
mrsa
infect
identif
mrsa
colon
approxim
davi
et
al
dilemma
rest
ethic
question
relat
screen
two
viewpoint
first
approach
would
screen
hospit
patient
time
admiss
approach
use
target
activ
surveil
screen
patient
high
risk
mrsa
colon
infect
exampl
highrisk
group
list
tabl
goal
screen
program
erad
mrsa
patient
reduc
risk
subsequ
mrsa
infect
hospit
healthcar
worker
hospit
patient
rel
usual
includ
mrsa
screen
program
sinc
goal
program
complet
erad
mrsa
commun
carbapenemhydrolyz
known
k
pneumonia
carbapenemas
produc
resist
strain
associ
higher
mortal
infect
patient
compar
patient
infect
carbapenemsensit
strain
use
surveil
cultur
identifi
popul
asymptomat
colon
patient
enhanc
effect
carbapenemresist
k
pneumonia
infect
prevent
program
calfe
jenkin
neurosurgeryopen
spinal
implant
approach
lead
develop
us
food
drug
administr
fda
approv
molecular
diagnost
test
detect
drug
resist
bacteria
rapid
turnaround
time
screen
result
june
genom
sequenc
bacteri
speci
avail
onlin
fournier
et
al
approxim
project
ongo
hernandez
et
al
rapid
progress
attribut
highthroughput
sequenc
technolog
mardi
comput
assembl
sequenc
hernandez
et
al
project
provid
genotypetophenotyp
revel
relat
detect
resist
antimicrobi
identif
virul
factor
better
understand
hostpathogen
interact
fournier
et
al
larger
scale
metagenom
sampl
genom
sequenc
commun
microbi
organ
inhabit
common
environ
hagenholtz
tyson
one
exampl
human
microbiom
project
intern
effort
map
humanassoci
microbi
commun
gut
mouth
skin
vagina
sequenc
streptococcu
sui
sequenc
type
st
respons
two
larger
outbreak
china
jiangui
sichuan
provinc
sporad
infect
sever
provinc
china
demonstr
presenc
tetracyclin
resist
gene
tetm
ye
et
al
tetm
gene
associ
conjug
transposon
horizont
transfer
tetm
gene
play
central
role
evolut
epidem
sui
st
clone
also
three
virul
gene
sui
st
includ
mrp
sli
ef
detect
pcr
speci
studi
ye
et
al
horizont
gene
transfer
exchang
dna
prokaryot
use
sever
mechan
conjug
transform
phage
transduct
horizont
gene
transfer
account
genet
plastic
permit
acquisit
new
virul
factor
antibiot
resist
metabol
toxic
compound
bacteri
strain
sinc
six
new
respiratori
virus
detect
tabl
dong
et
al
outbreak
sever
acut
respiratori
syndrom
sar
guangdong
provinc
china
repres
potenti
intern
chao
emerg
infecti
diseas
creat
zhao
mazzulli
et
al
first
index
case
locat
citi
foshan
west
guangzhou
provinc
fever
greater
respiratori
symptom
novemb
hospit
novemb
recov
januari
infect
wife
three
rel
zhao
sar
spread
countri
confirm
case
death
three
month
dong
et
al
zhao
largest
outbreak
sar
outsid
asia
toronto
canada
peopl
diagnos
peopl
die
mazulli
et
al
symptom
includ
fever
temperatur
greater
nonproduct
cough
myalgia
headach
malais
incub
period
day
diseas
spread
onset
symptom
recoveri
diseas
intern
effort
lead
identif
novel
coronaviru
level
pathogen
publish
sequenc
may
tor
strain
toronto
outbreak
assay
detect
sarscov
use
pcr
develop
viral
rna
detect
viral
load
upper
respiratori
tract
fece
low
first
four
day
peak
around
day
ill
zhao
intern
econom
effect
sar
estim
billion
cancel
travel
decreas
hotel
occup
china
canada
estim
contribut
decreas
nation
economi
outbreak
demonstr
import
molecular
techniqu
use
establish
ident
infecti
agent
within
seven
month
present
index
case
find
rapidli
follow
rtpcr
assay
detect
sarscov
patient
specimen
espi
et
al
without
techniqu
contain
outbreak
may
taken
much
longer
increas
number
infecti
organ
threaten
health
human
result
multipl
factor
includ
rapid
pathogen
mutat
rate
threat
bioterror
nelson
wilson
need
rapid
identif
pathogen
septic
patient
transform
nonhuman
pathogen
human
pathogen
wolf
et
al
outbreak
emerg
novel
infecti
diseas
zitterkopf
clafe
jenkin
ye
et
al
dong
et
al
zhao
mazzulli
et
al
jone
et
al
gener
dilemma
clinic
need
identif
pathogen
hour
facilit
initi
therapi
zitterkopf
calfe
jenkin
cultur
method
virus
bacteria
fungi
requir
day
result
identif
bacterium
molecular
method
provid
inform
relat
antibiot
sensit
organ
mrsa
exampl
except
gener
therefor
bacteria
need
cultur
complet
sensit
studi
microarray
design
detect
common
gramposit
gramneg
bacteri
pathogen
could
use
initi
screen
emerg
depart
intens
care
unit
miniatur
space
requir
extract
nucleic
acid
add
reagent
pcr
thermocycl
amplif
holland
kiechl
could
lead
develop
molecular
diagnost
devic
small
enough
move
patient
patient
pointofcar
test
technolog
would
simpl
use
could
employ
underdevelop
countri
rapid
identif
infecti
organ
dong
et
al
microbiolog
laboratori
microorgan
studi
freeli
suspend
cell
nutrientrich
cultur
media
refer
plankton
growth
howev
human
bacteri
infect
caus
microorgan
grow
sessil
state
biofilm
tabl
donlan
lynch
peterson
spread
respiratori
secret
airborn
transmiss
rtpcr
clone
sequenc
identifi
organ
human
coronavirus
envelop
positivestrand
rnavirus
caus
common
cold
genet
variabl
crossreact
must
monitor
use
molecular
asssay
detect
paramyxoviru
found
winter
spring
temper
climat
rtpcr
method
choic
detect
human
parvoviru
high
preval
coinfect
true
patholog
role
need
investig
biofilm
consist
polysaccharid
matrix
dna
protein
form
extracellular
polymer
substanc
extracellular
polymer
substanc
may
account
total
carbon
biofilm
donlan
biofilm
may
form
surgic
nonsurg
place
indwel
medic
devic
may
associ
chronic
infect
unrel
presenc
foreign
bodi
tabl
biofilm
time
less
suscept
antimicrobi
compar
organ
grown
suspens
sever
factor
may
play
role
antibiot
resist
lynch
robertson
first
extrapolymer
matrix
biofilm
may
trap
antibiot
howev
antibiot
antifung
capabl
diffus
biofilm
second
differ
gene
upregul
downregul
plankton
growth
compar
biofilm
exampl
aureu
grow
biofilm
upregul
gene
encod
enzym
involv
glycolysi
ferment
donlan
metabol
shift
ferment
attribut
oxygenlimit
biofilm
environ
biofilm
growth
may
also
upregul
multidrug
efflux
pump
reduc
antibiot
concentr
within
bacteria
final
subset
persist
cell
within
biofilm
slowgrow
geneticali
program
surviv
exposur
antibiot
lynch
robertson
mutant
grow
presenc
antibiot
express
toxin
rel
e
drive
persist
organ
dormant
state
highthroughput
screen
assay
develop
determin
effect
small
molecul
disrupt
biofilm
develop
junker
clardi
biofilm
intercellular
commun
occur
autoinduceractiv
intracellular
signal
intracellular
concentr
autoinduc
reach
threshold
bacteri
popul
whole
alter
gene
express
donlan
junker
clardi
microb
genom
may
regul
process
call
quorum
sens
autoinduc
use
sever
gramneg
organ
acyl
homoserin
lacton
hsl
exampl
quorum
sens
control
express
virul
gene
includ
lasb
lasa
apr
toxa
lasi
use
two
quorumsens
system
la
rhl
lasi
gene
product
direct
format
diffus
extracellular
signal
n
lhsl
autoinduc
interact
lasr
activ
virul
gene
gene
express
requir
p
aerginosa
biofilm
format
suppress
presenc
halogen
furanon
structur
similar
hsl
interfer
recept
biofilm
format
signal
junker
clardi
alter
quorum
sens
mechan
may
effect
method
treat
infect
caus
biofilm
microrna
mirna
nucleotid
long
noncod
regul
gene
express
directli
target
specif
mrna
molecul
mrna
degrad
inhibit
translat
sinc
first
report
viral
mirna
identifi
grey
nelson
beta
herpesviru
human
cytomegaloviru
gener
mirna
tabl
rider
et
al
alpha
herpesviru
herp
simplex
viru
type
four
gamma
herpesvirus
kaposi
sarcomaassoci
herpesviru
epsteinbarr
viru
rhesu
lymphocryptoviru
mous
gamma
herpesviru
also
larg
dna
virus
encod
mirna
mirna
transcrib
rna
polymeras
ii
nucleu
singlestrand
rna
precursor
call
primari
mirna
nuclear
rnase
iii
endonucleas
enzym
drosha
excis
nucleotid
hairpin
twonucleotid
overhang
primari
mirna
stemloop
structur
call
premirna
transport
cytoplasm
exportin
rangtpdepend
manner
rider
et
al
cytoplasm
rnase
iii
type
endonucleas
dicer
remov
stem
loop
premirna
creat
doublestrand
rna
twonucleotid
overhang
strand
duplex
unwound
one
strand
preferenti
load
protein
complex
call
rnainduc
silenc
complex
risc
load
singlestrand
rna
call
guid
strand
direct
endonucleas
within
risc
cleav
mrna
perfect
nearperfect
homolog
guid
strand
nucleotid
posit
mirna
function
seed
region
guid
strand
lessstring
homolog
mirna
site
within
untransl
region
target
lead
inhibit
translat
rather
mrna
degrad
approxim
human
mirna
sequenc
regul
gene
express
divers
area
like
immun
respons
neural
develop
dna
repair
apoptosi
oxid
stress
respons
candid
mirna
sequenc
locat
human
cytomegaloviru
hcmv
use
comput
algorithm
call
stemloop
finder
grey
nelson
function
target
viral
mirna
larg
unknown
hcmv
mirna
might
downregul
cellular
mrna
encod
antivir
factor
cullen
herp
virus
mirna
cluster
small
region
genom
cluster
occur
hcmv
genom
rider
et
al
viral
protein
product
larg
dna
virus
tempor
regul
three
phase
cullen
immedi
earli
phase
gener
regulatori
protein
earli
phase
provid
divers
array
protein
includ
need
viral
genom
replic
late
phase
gener
primarili
structur
protein
hcmv
mirna
classifi
earli
gene
two
mirna
mir
immedi
earli
gene
rider
et
al
role
mirna
may
play
hcmv
latent
product
replic
cycl
rel
unknown
hcmv
sever
mechan
avail
prevent
program
cell
death
apoptosi
infect
cell
hcmv
genom
encod
mitochondrialloc
inhibitor
apoptosi
well
inhibitor
caspas
apoptosi
hcmv
noncod
rna
produc
earli
viral
replic
phase
hold
compon
mitochondri
respiratori
chain
complex
togeth
stabil
ensur
complex
remain
bound
inner
mitochondri
membran
thu
prevent
apoptosi
hcmv
mirna
target
mrna
encod
major
histocompat
complex
class
polypeptiderel
sequenc
micb
micb
cellular
ligand
activ
receptor
express
natur
killer
nk
cell
nk
cell
activ
result
death
hcmvinfect
cell
propos
target
untransl
read
frame
micb
mrna
cell
produc
less
cellsurfac
micb
resist
nk
cell
kill
mutant
cell
without
abund
micb
bound
receptor
activ
nk
cell
kill
cullen
grey
nelson
rider
et
al
hcmb
mirna
also
downregul
express
hcmv
gene
involv
replic
restrict
viral
replic
help
maintain
infect
cell
longev
reduc
product
toxic
viral
protein
target
host
mrna
encod
immedi
earli
protein
ie
ie
regul
transcript
viral
gene
requir
viral
replic
nearli
two
dozen
distinct
leishmania
speci
caus
infect
multipl
endem
area
children
adult
murray
et
al
annual
approxim
million
children
adult
develop
symptomat
diseas
cutan
million
viscer
million
approxim
death
per
year
seventi
approxim
known
sandfli
speci
transmit
leishmaniasi
innocul
skin
flagel
promastigot
promastigot
invad
macrophag
neutrophil
transform
replic
amastigot
infect
macrophag
diseas
produc
vari
tremend
depend
speci
host
respons
infect
region
origin
tabl
murray
et
al
viscer
leishmaniasi
kalaazar
result
widespread
invas
disabl
mononuclearphagocyt
system
leishmania
donovani
rare
l
amazonensi
cutan
pathogen
especi
immunocompromis
patient
viscer
leishmaniasi
common
southern
asia
sudan
tabl
lead
mark
organomeg
especi
spleen
liver
uniformli
fatal
treat
viscer
leishmaniasi
especi
india
due
l
donovani
donovani
infect
human
spread
human
human
murray
et
al
mucocutan
leishmaniasi
nasooropharyng
leishmaniasi
sever
hypererg
highli
disfigur
diseas
endem
part
south
america
especi
brazil
caus
primari
l
braziliensi
braziliensi
sometim
l
braziliensi
guyanensi
occasion
similar
classic
lesion
occur
infect
organ
l
mexicana
complex
especi
l
mexicana
amazoniensi
murray
et
al
cutan
leishmaniasi
rel
local
mild
diseas
amastigot
circul
activ
leishmaniasi
parasitemia
frequent
immunodefici
patient
hiv
associ
kalaazar
howev
asymptomat
parasitemia
also
occur
immunosuppress
individu
subclin
viscer
infect
murray
et
al
leishmaniasi
infecti
diseas
preval
underdevelop
countri
limit
access
cultur
techniqu
molecular
diagnost
method
undevelop
countri
leishmaniasi
endem
microscop
observ
amastigot
clinic
specimen
prefer
diagnost
method
cutan
mucocutan
viscer
leishmaniasi
murray
et
al
reithing
dujardin
fingerstick
blood
test
use
rapid
detect
antibodi
use
immunochromatograph
strip
field
detect
symptomat
patient
kalaazar
sensit
assay
murray
et
al
reitthing
dujardin
leishmania
spp
hemoflagel
giant
mitochondrion
call
kinetoplast
locat
adjac
basal
bodi
flagellum
consist
dna
maxicircl
minicircl
equal
total
dna
minicircl
use
dna
target
due
larg
number
per
cell
repeat
sequenc
also
attract
pcr
target
espi
et
al
reithing
dujardin
howev
kinetoplast
dna
high
degre
polymorph
therefor
appropri
intern
control
leishmania
standard
control
need
use
adequ
monitor
qualiti
assay
espi
et
al
reithing
dujardin
rrna
target
use
success
simpl
complex
assay
design
identif
leishmania
spp
reithing
dujardin
work
remain
done
develop
simpl
reliabl
pointofcar
molecular
techniqu
use
underdevelop
countri
leishmania
spp
identif
genom
three
leishmania
spp
l
braziliensismucocutan
leishmaniasi
l
majorcutan
leishmaniasi
l
infantumviscer
leishmaniasi
one
sandfli
vector
lutzomyia
longopolpi
sequenc
date
l
major
code
gene
pseudogen
compar
l
infantum
code
gene
pseudogen
l
braziliensi
code
gene
pseudogen
peacock
et
al
lack
function
inform
relat
gene
identifi
l
braziliensi
featur
distinct
l
major
l
infantum
l
braziliensi
chromosom
two
l
braziliensi
one
three
mirna
could
function
genesilenc
agent
gene
identifi
encod
dicerlik
protein
convert
doublestrand
rna
small
singlestrand
mirna
also
gene
encod
argonaut
protein
slicer
endonucleas
found
risc
cleav
mrna
contain
sequenc
homolog
singlestrand
rna
call
guid
strand
within
risc
peacock
et
al
effort
determin
gene
specif
locat
one
leishmania
spp
direct
specif
host
respons
virul
factor
diseas
sever
reveal
noth
signific
time
howev
function
entir
set
gene
within
genom
identifi
type
investig
may
becom
fruit
exponenti
explos
molecular
assay
detect
infecti
agent
aid
rapid
identif
treatment
specif
infecti
diseas
espi
et
al
reithing
dujardin
rapid
detect
respiratori
virus
multipl
assay
commerci
avail
howev
screen
gramneg
gramposit
bacteri
agent
microarray
multiplex
format
still
feasibl
use
rdna
pcr
fail
detect
signific
number
cultureproven
newborn
septic
event
jordan
et
al
anoth
target
may
need
explor
avail
reliabl
simpl
portabl
molecular
devic
need
underdevelop
countri
detect
endem
infecti
diseas
caus
parasit
fungi
virus
bacteria
dong
et
al
develop
miniatur
molecular
techniqu
use
microfluid
smaller
volum
specimen
reagent
lead
way
solut
futur
holland
kiechl
era
number
molecular
assay
infecti
agent
need
clinic
greater
number
current
avail
year
ahead
see
classic
microbiolog
laboratori
function
decreas
new
molecular
method
introduc
perform
initi
detect
drug
sensit
infecti
agent
